CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $49,999,983
- in 2 filings
- Open-market sales, last 90 days
- $215,781
- in 9 filings
Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 41 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-10 | Hill Stephen J. Chief Operating Officer | Grant or award · Option (right to buy) | +450,000 | 450,000 | ||
| 2025-02-10 | Hill Stephen J. Chief Operating Officer | Grant or award · Option (right to buy) | +56,250 | 56,250 | ||
| 2025-02-10 | Newton Charles W. Chief Financial Officer | Grant or award | +112,500 | 172,725 | ||
| 2025-02-10 | Newton Charles W. Chief Financial Officer | Grant or award · Option (right to buy) | +450,000 | 450,000 | ||
| 2025-02-10 | Newton Charles W. Chief Financial Officer | Grant or award · Option (right to buy) | +56,250 | 56,250 | ||
| 2025-02-10 | Lee Gary K. Chief Scientific Officer | Grant or award | +112,500 | 176,696 | ||
| 2025-02-10 | Lee Gary K. Chief Scientific Officer | Grant or award · Option (right to buy) | +450,000 | 450,000 | ||
| 2025-02-10 | Lee Gary K. Chief Scientific Officer | Grant or award · Option (right to buy) | +56,250 | 56,250 | ||
| 2024-10-31 | Ramachandra Sumant Director | Grant or award · Option (right to buy) | +260,000 | 260,000 | ||
| 2024-06-14 | NELSEN ROBERT Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-14 | Bishop Hans Edgar Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-14 | Klausner Richard Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-14 | RIEFLIN WILLIAM JL Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-14 | NABEL ELIZABETH G Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-14 | BRAWLEY OTIS W Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-14 | FRIEDMAN CATHY Director | Grant or award · Option (right to buy) | +130,000 | 130,000 | ||
| 2024-02-09 | Lang Matthew Chief Business Officer | Grant or award | +50,000 | 50,000 | ||
| 2024-02-09 | Lang Matthew Chief Business Officer | Grant or award · Option (right to buy) | +500,000 | 500,000 | ||
| 2024-02-09 | Hill Stephen J. Chief Operating Officer | Grant or award | +40,000 | 48,928 | ||
| 2024-02-09 | Hill Stephen J. Chief Operating Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 |
Page 6 of 8 · 156 trades